In this op-ed article, Asim Siddiqui, Seer’s VP of Research and Technical Development, delves into the progressive landscape of mass spectrometry-based proteomics, where scientific strides are steering health and disease exploration. He discusses how advanced automation and enriched protein coverage are propelling population-scale studies, ushering in a new era of insights and pushing the boundaries of biological discovery.